A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (Integrative Management in Japan for Epidemic Disease by prophylactic study: IMJEDI P1 study)

Peer Review reports

Original Submission
15 Nov 2020	Submitted	Original manuscript
17 Nov 2020	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
30 Nov 2020	Editorially accepted
6 Jan 2021	Article published	10.1186/s13063-020-04939-2

Back to article page